Medicine Contracts with Accession Option
Arzneimittelverträge mit Beitrittsoption
Germany · Wuppertal · how to bid here →
Your path to submission
- Deadline: 1 November at 12:00 — 25 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU, DEU.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every 2 months (81 awards, most recently August 2026) — the next award is due around October 2026 by that rhythm. The last award went to BG Hexal 1 A Pharma GbR.n = 81
- The median procedure drew 6 bids (277 procedures with a bid count); 17% ended with a single bidder. Sector: median 2 bids.n = 277
- 50% of this buyer's awards went to companies that had already won here before (279 awards since 2024, spread over 134 companies). That is well below the sector norm (62%) — this buyer switches suppliers more often than others.n = 279 awards since 2024
- < 1% of the bids received came from other countries (149 procedures with a bid mix) — all bidders, not just the winners. Sector: 5%.n = 149
- From notice to award takes a median 137 days here (89 procedures). Sector: 90 days.n = 89
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 06/10/2026.
Foreign bidders
In Germany · Medical equipment & pharma, 265 contracts went to foreign companies over the last 3 years (of 22,200 recorded awards) — mostly from Austria, Netherlands, France.
Submission language: DEU.
Typical field: median 11 (from 81 awards).
What the buyer is looking for
The subject matter of the contract is medicinal products containing the active substance adalimumab. · The subject matter of the contract are medicinal products containing the active substance baclofen. · The subject of the contract are medicinal products containing the active substances beclometason dipropionate + formoterol + glycopyrronium cation (DOS). · The subject of the contract are medicinal products containing the active substances beclometason dipropionate + formoterol + glycopyrronium cation (IHP). · The subject of the contract are medicinal products containing the active substance betaine (Rx). · The subject of the contract are medicinal products containing the active substances brinzolamide + timolol. · The subject of the contract are medicinal products containing the active substance cabergolin (ATC N04BC06). · The subject of the contract are medicinal products containing…
Show full description
… the active substance clindamycin (vaginal). · The subject of the contract are medicinal products containing the active substance clomipramin. · The subject of the contract are medicinal products containing the active substance desloratadine (OTC, AM-RL Annex I). · The subject of the contract are medicinal products containing the active substance dexamethasone (ATC S01BA01, without IMP). · The subject of the contract are medicinal products containing the active substances dexamethasone + gentamicin. · The subject matter of the contract is medicinal products containing the active substance iron(II) ion (ATC B03AA07, OTC, AM-RL Annex I, without NEM). · The subject of the contract are medicinal products containing the active substance iron(III) hydroxide sucrose complex. · The subject of the contract are medicinal products containing the active substance fentanyl (nasal). · The subject of the contract are medicinal products containing the active substance follitropin alfa. · The subject matter of the contract are medicinal products containing the active substance ganirelix. · The subject of the contract are medicinal products containing the active substance gentamicin (ATC J01GB03). · The subject of the contract are medicinal products containing the active substance gentamicin (ATC S01AA11). · The subject of the contract are medicinal products containing the active substance iodide ion (ATC H03CA, OTC, AM-RL Annex I, without NEM). · The subject of the contract are medicinal products containing the active substance lanreotide. · The subject of the contract are medicinal products containing the active substance latanoprost (EDO). · The subject of the contract are medicinal products containing the active substance lenograstim. · The subject of the contract are medicinal products containing the active substance levothyroxine (excluding LSE_TRO). · The subject matter of the contract are medicinal products containing the active substance lipegfilgrastim. · The subject matter of the contract are medicinal products containing the active substance megestrol. · The subject of the contract are medicinal products containing the active substance raltegravir (without GSE). · The subject matter of the contract are medicinal products containing the active substance ribociclib. · The subject of the contract are medicinal products containing the active substance sevelamer hydrochloride. · The subject matter of the contract are medicinal products containing the active substance somatropin. · The subject of the contract are medicinal products containing the active substance sultamicillin (without PSE). · The subject matter of the contract are medicinal products containing the active substances tiotropium cation + olodaterol.
What you must prove — eligibility criteria
Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverlässigkeit) . Anlage E1 (Zuverläss… ▸▾
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| AMAROX PHARMA GmbH · Haar | 6 | 2025–2026 |
| Zentiva Pharma GmbH · Frankfurt am Main | 6 | 2025–2026 |
| Basics GmbH · Leverkusen | 5 | 2026 |
| Werbeartikel Muesch e.K. · Troisdorf | 5 | 2024–2025 |
| T-Systems International GmbH · Düsseldorf | 5 | 2024–2025 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.